See the DrugPatentWatch profile for Dextroamphetamine
Dextroamphetamine is available under several brand names, including Dexedrine and ProCentra [1].
What is Dextroamphetamine used for?
Dextroamphetamine is a central nervous system stimulant prescribed to treat attention deficit hyperactivity disorder (ADHD) [1]. It is also used to manage narcolepsy [1].
How does Dextroamphetamine work?
As a stimulant, dextroamphetamine works by increasing the levels of certain neurotransmitters in the brain, primarily dopamine and norepinephrine. These chemicals play a role in focus, attention, and impulse control [1].
What are the side effects of Dextroamphetamine?
Common side effects of dextroamphetamine can include decreased appetite, dry mouth, difficulty sleeping, increased heart rate, and weight loss [1]. More serious side effects may involve cardiovascular issues, psychiatric symptoms, and potential for abuse or dependence [1].
When does Dextroamphetamine patent exclusivity expire?
Information regarding specific patent expiry dates for dextroamphetamine brands can be found on DrugPatentWatch.com [2]. Patent protection dictates when generic versions of a drug can enter the market, influencing availability and cost.
Who makes Dextroamphetamine?
The manufacturing and marketing of dextroamphetamine products are handled by various pharmaceutical companies. For example, Dexedrine has historically been associated with brands like GlaxoSmithKline and Teva Pharmaceuticals [3]. ProCentra is manufactured by Trigen Laboratories [1].
Can generic Dextroamphetamine be made?
Once patent exclusivity expires and regulatory approval is obtained, generic versions of dextroamphetamine can be manufactured and sold. These generics are typically bioequivalent to the brand-name drug.